Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (10601)	7/1/1999 10:11:00 PM
From: Bluegreen	Read Replies (2) \| Respond to of 17367

I am not talking super just regular. Say for example you are just checking throughout the day on regular, is there anything wrong with that? Wouldn't you do that in trying to figure out parameters BEFORE you go to super?

To: aknahow who wrote (10601)	7/5/1999 11:16:00 AM
From: aknahow	Read Replies (1) \| Respond to of 17367

Comments???? <<<<<<<<<<NASHVILLE, TN -- July 2, 1999 -- Could a common bacterium be involved in the development of multiple sclerosis? In this month's Annals of Neurology, researchers report finding evidence of the bacterium Chlamydia pneumoniae in all the multiple sclerosis (MS) patients in their study. >>>>>>>>snip>>>>>. pslgroup.com XOMA patent 5,888,973 for reference. Anti-chlamydial uses of BPI protein products 164.195.100.11